bluebird bio

PsiOxus and bluebird bio recently presented novel data combining PsiOxus’ T-SIGn platform with bluebird bio’s CAR-T therapy to clear primary tumors and metastases. Click here to find out more.


Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image
Menu